Is macitentan not a treatment option for digital ulcers in systemic sclerosis?
作者信息
Asano Yoshihide
机构信息
Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
出版信息
Ann Transl Med. 2016 Oct;4(Suppl 1):S6. doi: 10.21037/atm.2016.08.67.
Abstract
摘要
相似文献
1
Is macitentan not a treatment option for digital ulcers in systemic sclerosis?
Ann Transl Med. 2016 Oct;4(Suppl 1):S6. doi: 10.21037/atm.2016.08.67.
2
Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials.
JAMA. 2016 May 10;315(18):1975-88. doi: 10.1001/jama.2016.5258.
3
Swift and Complete Healing of Digital Ulcers after Macitentan Treatment.
Case Rep Rheumatol. 2016;2016:1718309. doi: 10.1155/2016/1718309. Epub 2016 Nov 22.
4
Macitentan: An important addition to the treatment of pulmonary arterial hypertension.
J Pharmacol Pharmacother. 2015 Jan-Mar;6(1):53-7. doi: 10.4103/0976-500X.149151.
5
An anti-RNA polymerase III antibody-positive systemic sclerosis patient with thymic carcinoma whose digital ulcers healed during treatment with macitentan and sildenafil for pulmonary arterial hypertension.
Eur J Dermatol. 2020 Apr 10. doi: 10.1684/ejd.2020.3747.
6
Exploring the patient experience of digital ulcers in systemic sclerosis.
Semin Arthritis Rheum. 2019 Apr;48(5):888-894. doi: 10.1016/j.semarthrit.2018.08.001. Epub 2018 Aug 11.
7
Effects of macitentan and its active metabolite on cultured human systemic sclerosis and control skin fibroblasts.
J Rheumatol. 2015 Mar;42(3):456-63. doi: 10.3899/jrheum.141070. Epub 2015 Jan 15.
8
Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
J Rheumatol. 1992 Sep;19(9):1407-14.
9
Optimal management of digital ulcers in systemic sclerosis.
Ther Clin Risk Manag. 2015 Jun 15;11:939-47. doi: 10.2147/TCRM.S82561. eCollection 2015.
10
[Marked effect of botulinum toxin A for severe toe digital ulcers in a patient with systemic sclerosis].
Ugeskr Laeger. 2014 Feb 17;176(8A):V08130527.
引用本文的文献
1
Macitentan in the treatment of severe digital ulcers.
BMJ Case Rep. 2019 Aug 12;12(8):e228295. doi: 10.1136/bcr-2018-228295.
本文引用的文献
1
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis.
Mod Rheumatol. 2017 Jan;27(1):110-114. doi: 10.1080/14397595.2016.1192761. Epub 2016 Jun 16.
2
Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials.
JAMA. 2016 May 10;315(18):1975-88. doi: 10.1001/jama.2016.5258.
3
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.
Lancet. 2016 Jun 25;387(10038):2630-2640. doi: 10.1016/S0140-6736(16)00232-4. Epub 2016 May 5.
4
Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.
Br J Dermatol. 2016 Feb;174(2):338-47. doi: 10.1111/bjd.14183. Epub 2015 Nov 21.
5
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients.
J Clin Invest. 2015 Jul 1;125(7):2795-807. doi: 10.1172/JCI77958. Epub 2015 Jun 22.
6
Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study.
Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S148-52. Epub 2015 Jun 19.
7
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group.
Ann Rheum Dis. 2015 Jun;74(6):1188-94. doi: 10.1136/annrheumdis-2013-204522. Epub 2014 Jan 17.
8
In systemic sclerosis patients, bosentan is safe and effective for digital ulcer prevention and it seems to attenuate the development of pulmonary arterial hypertension.
Rheumatology (Oxford). 2014 Mar;53(3):570-1. doi: 10.1093/rheumatology/ket424. Epub 2013 Dec 18.
9
Macitentan and morbidity and mortality in pulmonary arterial hypertension.
N Engl J Med. 2013 Aug 29;369(9):809-18. doi: 10.1056/NEJMoa1213917.
10
Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility.
QJM. 2013 Sep;106(9):839-48. doi: 10.1093/qjmed/hct111. Epub 2013 May 21.
Zotero 插件